Technology ID
TAB-4944
Generation and Application of c-Cbl floxed Transgenic Mice for Conditional Gene Deletion Studies
E-Numbers
E-136-2017-0
Lead Inventor
Gu, Hua
Lead IC
NIAID
ICs
NIAID
Applications
Therapeutics
Research Materials
Diagnostics
Therapeutic Areas
Rare/Neglected Diseases
Oncology
Immunology
Development Stages
Pre-clinical (in vivo)
Research Products
Animal Models
This technology presents a novel strain of transgenic mice where the proto-oncogene c-Cbl (Casitas B-lineage lymphoma) has been engineered with loxP (locus of X-over P1) sites, commonly referred to as "floxed." This design enables the conditional knockout of the c-Cbl gene when the mice are crossed with strains that express the Cre recombinase enzyme. Cre recombinase is an enzyme that can specifically target loxP sites, excising the floxed gene only in the presence of Cre, thus allowing tissue-specific or temporal deletion of the target gene.
Commercial Applications
The c-Cbl fl/fl transgenic mice hold vast potential across multiple applications in biomedical research. They are particularly valuable for uncovering the functions of c-Cbl in disease models, such as in oncogenesis, where c-Cbl’s role in cell signaling and tumor suppression can be elucidated. In immunology, these mice can be used to study c-Cbl's impact on immune cell development and autoimmune diseases. Their use can extend to pharmacology for testing the efficacy and toxicity of new drugs targeting the c-Cbl pathway. Furthermore, they could be instrumental in gene therapy research by offering insights into the safe and effective delivery of gene-editing tools to specific tissues. This conditional deletion model could also serve as a template for developing other genetically modified organisms to study different genes with similar precision, broadening the scope of genetic research and its translational applications to therapeutic interventions.
Competitive Advantages
The c-Cbl fl/fl transgenic mice represent a unique resource that allows for conditional gene manipulation with high specificity. Their ability to enable targeted gene deletion in a tissue-specific manner offers a significant advantage over traditional knockout models, which can lead to embryonic lethality or compensatory mechanisms that obscure the gene's function. These mice provide a refined model to study the intricate roles of genes in various biological processes and diseases, particularly cancer and immune function. Moreover, the precision of this genetic approach facilitates the dissection of complex pathways, potentially accelerating the discovery of novel drug targets and enhancing the understanding of gene function in vivo. This specificity and versatility position the c-Cbl fl/fl mice as an essential tool in advanced genetic research and therapeutic development.
Licensing Contact: